Skip to main page content
U.S. flag
See More

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;254(2):199-211.
doi: 10.1002/path.5659. Epub 2021 May 6.

The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma

Manuel Ruh  1 , Marc P Stemmler  1 , Isabell Frisch  1 , Kathrin Fuchs  1 , Ruthger van Roey  1 , Julia Kleemann  1 , Maike Roas  1 , Harald Schuhwerk  1 , Rebecca L Eccles  1 , Abbas Agaimy  2 , Daniel Baumhoer  3 , Geert Berx  4   5 , Fabian Müller  6 , Thomas Brabletz  1   7 , Simone Brabletz  1
Affiliations

The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma

Manuel Ruh et al. J Pathol. 2021 Jun.

Abstract

Osteosarcoma is an often-fatal mesenchyme-derived malignancy in children and young adults. Overexpression of EMT-transcription factors (EMT-TFs) has been associated with poor clinical outcome. Here, we demonstrated that the EMT-TF ZEB1 is able to block osteoblastic differentiation in normal bone development as well as in osteosarcoma cells. Consequently, overexpression of ZEB1 in osteosarcoma characterizes poorly differentiated, highly metastatic subgroups and its depletion induces differentiation of osteosarcoma cells. Overexpression of ZEB1 in osteosarcoma is frequently associated with silencing of the imprinted DLK-DIO3 locus, which encodes for microRNAs targeting ZEB1. Epigenetic reactivation of this locus in osteosarcoma cells reduces ZEB1 expression, induces differentiation, and sensitizes to standard treatment, thus indicating therapeutic options for ZEB1-driven osteosarcomas. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.

Keywords: EMT; ZEB1; bone development; metastatic colonization; osteosarcoma; therapy.

PubMed Disclaimer

References

    1. Bacci G, Ferrari S, Longhi A, et al. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer 2001; 37: 32-38.
    1. Wagner ER, Luther G, Zhu G, et al. Defective osteogenic differentiation in the development of osteosarcoma. Sarcoma 2011; 2011: 325238.
    1. Nieto MA, Huang RY, Jackson RA, et al. EMT: 2016. Cell 2016; 166: 21-45.
    1. Yang J, Antin P, Berx G, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2020; 21: 341-352.
    1. Feng T, Zhu Z, Jin Y, et al. The microRNA-708-5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma. Oncol Rep 2020; 43: 491-502.

Publication types

MeSH terms

LinkOut - more resources